Scarica l'app Stockscreener
23.81
6.30%
-1.60
Dopo l'orario di chiusura:
23.50
-0.31
-1.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$25.41
Aprire:
$25.82
Volume 24 ore:
1.81M
Relative Volume:
3.43
Capitalizzazione di mercato:
$1.15B
Reddito:
$441.33M
Utile/perdita netta:
$9.76M
Rapporto P/E:
119.17
EPS:
0.1998
Flusso di cassa netto:
$839.00K
1 W Prestazione:
-32.99%
1M Prestazione:
-36.73%
6M Prestazione:
-49.19%
1 anno Prestazione:
-17.64%
Intervallo 1D:
$23.33
$25.83
Intervallo di 1 settimana:
$19.16
$36.26
Portata 52W:
$19.16
$48.25
Artivion Inc Stock (AORT) Company Profile
Nome
Artivion Inc
Settore
Industria
Telefono
(770) 419-3355
Indirizzo
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
23.81 | 1.23B | 441.33M | 9.76M | 839.00K | 0.1998 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-10 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2025-08-13 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2025-06-17 | Iniziato | Canaccord Genuity | Buy |
| 2024-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2022-09-27 | Reiterato | Lake Street | Buy |
| 2022-08-08 | Iniziato | Lake Street | Buy |
| 2022-03-03 | Iniziato | Stifel | Buy |
Mostra tutto
Artivion Inc Borsa (AORT) Ultime notizie
Shareholder Alert: Ademi LLP Investigates Claims of Securities Fraud Against Artivion, Inc. - Moomoo
CCORF Maintains Artivion(AORT.US) With Buy Rating, Maintains Target Price $36 - Moomoo
How Artivion’s Softer 2026 Outlook After Q1 Profit Turn Will Impact Artivion (AORT) Investors - Yahoo Finance
Should Artivion’s Lowered 2026 Guidance and Endospan Deal Require Action From Artivion (AORT) Investors? - simplywall.st
Nasdaq Jumps 200 Points; US Adds 115,000 Jobs In April - Sahm
Crude Oil Gains 1%; Fluor Shares Plunge After Q1 Results - Sahm
Artivion, Inc. (NYSE:AORT) Q1 2026 Earnings Call Transcript - Insider Monkey
Artivion Q1 Earnings Call Highlights - TradingView
Artivion (AORT) Earnings Turn Positive Challenging Cautious Profitability Narratives - Sahm
Artivion Stock Dips 28% In One Day, Now Is Not The Time To Buy The Stock - Trefis
Artivion Inc stock hits 52-week low at $27.31 By Investing.com - Investing.com Nigeria
Artivion Down Over 25%, On Pace for Largest Percent Decrease Since September 2022 -- Data Talk - Moomoo
Why Artivion (AORT) Stock Is Falling Today - Barchart.com
Why is Artivion stock plummeting today? By Investing.com - Investing.com Canada
ARTIVION, INC. 1Q 2026: Revenue $116.34M, EPS $0.03— 10-Q Summary - TradingView
Artivion | 10-Q: Q1 2026 Earnings Report - Moomoo
Artivion (NYSE: AORT) Q1 revenue rises 18% to $116M with profit - Stock Titan
Canaccord cuts Artivion stock price target on Q1 miss, lower guidance - Investing.com UK
Artivion Inc stock hits 52-week low at $27.31 - Investing.com
Q1 2026 Artivion Inc Earnings Call Transcript - GuruFocus
Canaccord cuts Artivion stock price target on Q1 miss, lower guidance By Investing.com - Investing.com South Africa
A Quick Look at Today's Ratings for Artivion(AORT.US), With a Forecast Between $36 to $48 - Moomoo
Artivion Q1 2026 slides: earnings beat overshadowed by lowered guidance - Investing.com Australia
Citizens cuts Artivion stock price target on softer stent graft sales By Investing.com - Investing.com South Africa
Citizens cuts Artivion stock price target on softer stent graft sales - Investing.com
Artivion: Q1 Earnings Snapshot - theheraldreview.com
Artivion Inc (NYSE:AORT) Stock Slides After Q1 Revenue Miss Despite Earnings Beat - ChartMill
Artivion Stock Slides on Plans to Acquire Endospan, Lower FY Guidance - Moomoo
Artivion Cuts 2026 View To Rev $480M-$496M >AORT - Moomoo
Earnings call transcript: Artivion Q1 2026 beats EPS forecast, stock dips slightly - Investing.com
Artivion Earnings Call Highlights Growth Amid Headwinds - TipRanks
Artivion (AORT) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Artivion (AORT) Q1 2026 Earnings Transcript - AOL.com
Artivion Acquires Endospan to Expand Aortic Arch Portfolio - TipRanks
Artivion reports Q1 revenue of $116.3M, lowers 2026 guidance By Investing.com - Investing.com South Africa
Artivion reports Q1 revenue of $116.3M, lowers 2026 guidance - Investing.com
Artivion’s (NYSE:AORT) Q1 CY2026 Earnings Results: Revenue In Line With Expectations - Yahoo Finance
Artivion (NYSE: AORT) grows Q1 sales, eyes Endospan acquisition - Stock Titan
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan - PR Newswire
Artivion earnings on deck: NEXUS approval raises growth stakes By Investing.com - Investing.com Australia
Artivion earnings on deck: NEXUS approval raises growth stakes - Investing.com India
Artivion Q1 2026 Earnings Call Transcript - MarketBeat
What To Expect From Artivion’s (AORT) Q1 Earnings - The Globe and Mail
Artivion Q1 2026 Earnings Preview — May 7, Street Expects $0.12 EPS - AlphaStreet
Earnings Preview: Artivion to Report Financial Results Post-market on May 07 - Moomoo
Freedom Capital Markets initiates Artivion stock with buy rating By Investing.com - Investing.com South Africa
Freedom Capital Markets initiates Artivion stock with buy rating - Investing.com
Artivion Inc Azioni (AORT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):